RBC indices as an early screening tool for thalassemia disease among anemic 9-month-old children
This prospective study demonstrates that combining an MCV ≤ 50 fL and an MCH ≤ 15 pg serves as a highly specific and practical screening criterion for identifying thalassemia among 9-month-old anemic children in Thailand, effectively guiding the need for confirmatory hemoglobin typing.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Anemia, a condition where the blood lacks enough healthy red cells to carry oxygen, is a widespread health challenge for young children around the world. In many places, the most common reason for this shortage is a simple lack of iron, a mineral essential for building hemoglobin, the molecule that gives blood its color and its ability to transport oxygen. Doctors often treat this by giving children iron supplements, which usually works well. However, in Thailand, there is another major cause of anemia that looks very similar on the surface but requires a completely different approach: thalassemia. This is an inherited condition where the body cannot make hemoglobin correctly. Because the symptoms and the initial blood test results for iron deficiency and thalassemia can look nearly identical, doctors face a difficult choice. They need a way to quickly spot which children have the inherited disorder so they can refer them for specific genetic testing, without wasting time and resources on children who simply need iron.
Researchers at Srinakarinwirot University in Thailand set out to find a practical solution for this problem by looking at very young children, specifically those who are nine months old. In their hospital, routine health checks for babies at this age include a blood test to check for anemia. The team wanted to see if they could use the standard numbers from that blood test to predict which of these anemic babies actually had thalassemia. They focused on two specific measurements: the average size of the red blood cells and the average amount of hemoglobin inside each cell. The logic was straightforward: if the cells are unusually small and carry very little hemoglobin, it might be a sign of the inherited disorder rather than just a lack of iron.
To test this idea, the researchers followed 185 infants who were found to have low hemoglobin levels during their nine-month checkups. Every child in the study received a month of iron supplements, a standard treatment for suspected iron deficiency. After that month, the team took another blood sample from each child. They then analyzed the blood to see how the children responded to the iron and, crucially, performed a detailed test to identify the exact type of hemoglobin each child had. This detailed test acted as the final truth, allowing the researchers to sort the children into groups: those with normal blood (who were presumed to have iron deficiency), and those with various forms of thalassemia.
The results showed that while iron helped many children, a significant portion of the group had thalassemia. Specifically, about 38 percent of the children had normal hemoglobin patterns, suggesting their anemia was likely due to iron deficiency or other causes. However, the remaining children had different types of thalassemia, including beta-thalassemia with Hb E, Hb H disease, and homozygous Hb E. When the researchers looked back at the blood test numbers from before the iron treatment, they found a clear pattern. The children who had thalassemia tended to have red blood cells that were much smaller and carried less hemoglobin than the other children.
The study identified a specific combination of numbers that worked best as a screening tool. If a nine-month-old child had red blood cells that were 50 femtoliters or smaller in size, and the hemoglobin inside each cell was 15 picograms or less, the odds of that child having thalassemia were very high. When the researchers used these two criteria together, they found that the method was highly accurate at ruling out children who did not have the disease. In fact, if a child did not meet these strict criteria, it was highly likely they did not have thalassemia, with a negative predictive value of over 97%. For the children who did meet the criteria, the test was also quite good at identifying them correctly, though it missed a few cases.
This approach offers a clear path forward for doctors in similar settings. Instead of ordering expensive and complex genetic tests for every single child with anemia, doctors can first check these two simple numbers from a standard blood test. If the numbers are above the threshold, the child can likely be treated with iron and monitored. If the numbers are at or below the threshold, the child should be sent for the specific hemoglobin typing test to confirm a diagnosis of thalassemia. The researchers noted that this method is not a perfect replacement for the genetic test, but it serves as a powerful filter. It helps ensure that the children who truly need specialized care are identified early, while preventing unnecessary testing for those who do not. By using these simple measurements, healthcare providers can make better decisions for the health of infants in their first year of life.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.